Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Total 13F shares
-
34,445,503
-
Share change
-
-8,064,701
-
Total reported value
-
$8,338,029,358
-
Put/Call ratio
-
94%
-
Price per share
-
$242.07
-
Number of holders
-
240
-
Value change
-
-$2,098,488,418
-
Number of buys
-
118
-
Number of sells
-
129
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q2 2025
As of 30 Jun 2025,
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) was held by
240 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,445,503 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Capital International Investors, FMR LLC, HHLR ADVISORS, LTD., PRICE T ROWE ASSOCIATES INC /MD/, Temasek Holdings (Private) Ltd, CITADEL ADVISORS LLC, Siren, L.L.C., and BlackRock, Inc..
This page lists
240
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.